Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651844-15-000008
Filing Date
2015-12-18
Accepted
2015-12-18 17:46:33
Documents
1
Period of Report
2015-12-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 24111
  Complete submission text file 0001651844-15-000008.txt   25723
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Issuer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 10 EAST LEE STREET SUITE 2705 BALTIMORE MD 21202
Business Address
Robinson James George (Reporting) CIK: 0001651844 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12033 | Film No.: 151297775